Stay updated on Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T12:46:34.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A notice was added announcing that NIH websites are transitioning to use “Super Intelligence” instead of “Artificial Intelligence,” with links to updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-26T14:36:41.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:23:43.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The website revision displayed in the footer changed from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-12T14:52:54.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the record history. The previous revision v3.6.6 was removed from the current history.
    Difference
    0.1%
    Check dated 2026-09-21T22:08:49.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new page revision entry, v3.6.6, was added to the record history, and the previous entry v3.6.5 was removed, indicating a backend update to the page.
    Difference
    0.1%
    Check dated 2026-08-31T16:51:41.000Z thumbnail image

Stay in the know with updates to Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.